1. Home
  2. ALDX vs EFSI Comparison

ALDX vs EFSI Comparison

Compare ALDX & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • EFSI
  • Stock Information
  • Founded
  • ALDX 2004
  • EFSI 1881
  • Country
  • ALDX United States
  • EFSI United States
  • Employees
  • ALDX N/A
  • EFSI N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • EFSI Major Banks
  • Sector
  • ALDX Health Care
  • EFSI Finance
  • Exchange
  • ALDX Nasdaq
  • EFSI Nasdaq
  • Market Cap
  • ALDX 160.8M
  • EFSI 158.7M
  • IPO Year
  • ALDX 2014
  • EFSI N/A
  • Fundamental
  • Price
  • ALDX $4.76
  • EFSI $33.01
  • Analyst Decision
  • ALDX Strong Buy
  • EFSI Strong Buy
  • Analyst Count
  • ALDX 2
  • EFSI 2
  • Target Price
  • ALDX $9.50
  • EFSI $40.00
  • AVG Volume (30 Days)
  • ALDX 1.2M
  • EFSI 57.9K
  • Earning Date
  • ALDX 07-31-2025
  • EFSI 08-25-2025
  • Dividend Yield
  • ALDX N/A
  • EFSI 3.74%
  • EPS Growth
  • ALDX N/A
  • EFSI N/A
  • EPS
  • ALDX N/A
  • EFSI 1.52
  • Revenue
  • ALDX N/A
  • EFSI $58,067,000.00
  • Revenue This Year
  • ALDX N/A
  • EFSI $3.16
  • Revenue Next Year
  • ALDX N/A
  • EFSI $22.35
  • P/E Ratio
  • ALDX N/A
  • EFSI $21.91
  • Revenue Growth
  • ALDX N/A
  • EFSI N/A
  • 52 Week Low
  • ALDX $1.14
  • EFSI $28.70
  • 52 Week High
  • ALDX $7.20
  • EFSI $36.93
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 78.74
  • EFSI N/A
  • Support Level
  • ALDX $4.12
  • EFSI N/A
  • Resistance Level
  • ALDX $4.60
  • EFSI N/A
  • Average True Range (ATR)
  • ALDX 0.29
  • EFSI 0.00
  • MACD
  • ALDX 0.08
  • EFSI 0.00
  • Stochastic Oscillator
  • ALDX 90.91
  • EFSI 0.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About EFSI Eagle Financial Services Inc Common Stock

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

Share on Social Networks: